COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,889 Articles (22,568 medRxiv, 8,321 bioRxiv)

Most recent first Previous |  Page 2347: Articles 23461-23470  | Next

Health systems trust in the time of Covid-19 pandemic in Bangladesh: A qualitative exploration
Joarder, T., Bin Khaled, M. N., Zaman, S.
10.1101/2020.08.05.20157768 — Posted: 2020-08-06
U.S. Field Hospitals: A Study on Public Health Emergency Response to COVID-19
Yuan, L., Sherryn, S., Hu, P., Chen, F.
10.1101/2020.08.05.20169094 — Posted: 2020-08-06
An Examination of School Reopening Strategies during the SARS-CoV-2 Pandemic
Landeros, A., Ji, X., Lange, K. L., Stutz, T. C., Xu, J., Sehl, M. E., Sinsheimer, J. S.
10.1101/2020.08.05.20169086 — Posted: 2020-08-06 Discussion: Onsite
Inflammasome activation in COVID-19 patients
Rodrigues, T. S., Sa, K. S., Ishimoto, A. Y., Becerra, A., Oliveira, S., Almeida, L., Goncalves, A. V., Perucello, D. B., Andrade, W. A., Castro, R., Veras, F. P., Toller-Kawahisa, J. E., Nascimento, D. C., de Lima, M. H., Silva, C. M., Caetite, D. B., Martins, R. B., Castro, I. A., Pontelli, M. C., de Barros, F. C., do Amaral, N. B., Giannini, M. C., Bonjorno, L. P., Lopes, M. I. F., Benatti, M. N., Santana, R. C., Vilar, F. C., Auxiliadora-Martins, M., Luppino-Assad, R., de Almeida, S. C., de Oliveira, F. R., Batah, S. S., Siyuan, L., Benatti, M. N., Cunha, T. M., Alves-Filho, J. C., Cunha
10.1101/2020.08.05.20168872 — Posted: 2020-08-06
First-in-Human Trial of a SARS CoV 2 Recombinant Spike Protein Nanoparticle Vaccine
Keech, C., Albert, G., Reed, P., Neal, S., Plested, J. S., Zhu, M., Cloney-Clark, S., Zhou, H., Patel, N., Frieman, M. B., Haupt, R. E., Logue, J., McGrath, M., Weston, S., Piedra, P. A., Cho, I., Robertson, A., Desai, C., Callahan, K., Lewis, M., Price-Abbott, P., Formica, N., Shinde, V., Fries, L., Linkliter, J. D., Griffin, P., Wilkinson, B., Smith, G., Glenn, G. M.
10.1101/2020.08.05.20168435 — Posted: 2020-08-06 Discussion: Onsite | Offsite
Repeat COVID-19 Molecular Testing: Correlation with Recovery of Infectious Virus, Molecular Assay Cycle Thresholds, and Analytical Sensitivity
Gniazdowski, V., Morris, C. P., Wohl, S., Mehoke, T., Ramakrishnan, S., Thielen, P., Powell, H., Smith, B. D., Armstrong, D. T., Herrera, M., Reifsnyder, C., Sevdali, M., Carroll, K. C., Pekosz, A., Mostafa, H. H.
10.1101/2020.08.05.20168963 — Posted: 2020-08-06 Discussion: Offsite
Transient dynamics of SARS-CoV-2 as England exited national lockdown
Riley, S., Ainslie, K. E. C., Eales, O., Walters, C. E., Wang, H., Atchison, C. J., Diggle, P., Ashby, D., Donnelly, C. A., Cooke, G., Barclay, W., Ward, H., Darzi, A., Elliott, P.
10.1101/2020.08.05.20169078 — Posted: 2020-08-06
Longitudinal analysis of clinical serology assay performance and neutralising antibody levels in COVID19 convalescents
Muecksch, F., Wise, H., Batchelor, B., Squires, M., Semple, E., Richardson, C., McGuire, J., Cleary, S., Furrie, E., Greig, N., Hay, G., Templeton, K., Lorenzi, J. C. C., Hatziioannou, T., Jenks, S. J., Bieniasz, P.
10.1101/2020.08.05.20169128 — Posted: 2020-08-06
Signatures and mechanisms of efficacious therapeutic ribonucleotides against SARS-CoV-2 revealed by analysis of its replicase using magnetic tweezers
Seifert, M., Bera, S. C., van Nies, P., Kirchdoerfer, R. N., Shannon, A., Le, T.-T.-N., Grove, T. L., Papini, F. S., Arnold, J. J., Almo, S. C., Canard, B., Depken, M., Cameron, C. E., Dulin, D.
10.1101/2020.08.06.240325 — Posted: 2020-08-06
Phylogenetic analysis of SARS-CoV-2 data is difficult
Morel, B., Barbera, P., Czech, L., Bettisworth, B., Huebner, L., Lutteropp, S., Serdari, D., Kostaki, E.-G., Mamais, I., Kozlov, A., Pavlidis, P. M., Paraskevis, D., Stamatakis, A.
10.1101/2020.08.05.239046 — Posted: 2020-08-06 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).